* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download agonist - Buffalo State
CCR5 receptor antagonist wikipedia , lookup
Discovery and development of beta-blockers wikipedia , lookup
Pharmacognosy wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Prescription costs wikipedia , lookup
Toxicodynamics wikipedia , lookup
NMDA receptor wikipedia , lookup
5-HT3 antagonist wikipedia , lookup
Drug discovery wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Theralizumab wikipedia , lookup
5-HT2C receptor agonist wikipedia , lookup
Drug interaction wikipedia , lookup
Psychopharmacology wikipedia , lookup
Drug design wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Drug Chemistry and Toxicology CHE 618 Alexander Nazarenko The Receptor Concept The Nature of Drug Receptors Drug Parameters: Affinity and Efficacy The Langmuir Isotherm equation Insulin receptor Opioid receptor Transmembrane receptor Occupation theory Drug effect is directly proportional to number of receptors occupied Drug effect ceases as drug-receptor complex dissociate Ariens & Stephenson theory introduced terms of "affinity" & "efficacy" Affinity: ability of the drug to combine with receptor to create drug-receptor complex Efficacy: ability of the drug-receptor complex to initiate a response Affinity “drug-receptor interaction” is governed by the law of mass action. In this theory Agonist: drug with high affinity & high intrinsic activity Partial agonist: drug with high affinity & low intrinsic activity Antagonist: drug with high affinity & low intrinsic activity Rate theory The activation of receptors is directly proportional to the total number of encounters of the drug with its receptors per unit time Pharmacological activity is directly proportional to the rate of dissociation & association not number of receptors occupied Agonist: drug with fast association & fast dissociation Partial agonist: drug with intermediate association & intermediate dissociation Antagonist: drug with fast association & slow dissociation Induced fit theory As the drug approaches the receptor the receptors alters the conformation of its binding site to produce drug—receptor complex An agonist is a chemical that binds to a receptor and triggers a response. Whereas an agonist causes an action, an antagonist blocks the action of the agonist and an inverse agonist causes an action opposite to that of the agonist. From the Greek αγωνιστής (agōnistēs), contestant; champion; rival < αγων (agōn), contest, combat; exertion, struggle < αγω (agō), I lead, lead towards, conduct; drive Drug + Receptor [Drug/Receptor Complex] K Action The Langmuir Isotherm C C 1 C K C β = 100 K = 1/100 = 0.01 1 0.8 0.6 0.4 0.2 0 0 0.05 0.1 0 0.0001 0.001 0.01 1 1 0.8 0.8 0.6 0.6 0.4 0.4 0.2 0.2 0 0 0.005 0.01 0.015 0.02 0.025 0.15 0.2 0.1 1 a Various plots 1 0.8 0.6 1/a 0.4 12 0.2 C y = 0.01x + 1 10 0 0 0.005 0.01 0.015 0.02 0.025 8 6 0.04 C/a 0.035 4 0.03 2 1/C 0 0 500 1000 0.025 0.02 y = x + 0.01 0.015 0.01 Lineweaver–Burk plot C 0.005 0 Hanes–Woolf plot 0 0.02 Michaelis–Menten kinetics Lineweaver–Burk or double-reciprocal plot of kinetic data, showing the significance of the axis intercepts and gradient. Vmax S V K S Michaelis-Menten Plot relating the reaction rate V to the substrate concentration [S]. Agonists Full agonists are able to activate the receptor and result in a maximal biological response. Partial Agonist Partial agonists do not activate receptors thoroughly, causing responses which are partial compared to those of full agonists Antagonist Antagonists bind to receptors but do not activate them. This results in receptor blockage, inhibiting the binding of other agonists. Inverse Agonist Inverse agonists reduce the activity of receptors by inhibiting their constitutive activity. Full Agonist +1 Functional Response Partial Agonist Neutral Antagonist 0 Full Inverse Agonist -1 Log[Drug] Competitive Antagonism A1 + Receptor A2 + Receptor {A1 Receptor} effect {A2 Receptor} [ A1 ] 1 [ A1 ] 2 [ A2 ] A1 A2 Receptor-A1 is active R [ A1 ] 1 [ A1 ] 2 [ A2 ] 12 [ A1 ] [ A2 ] A1 A1 R R R A2 Receptor-A1-A2 is active A2 12 [ A1 ] [ A2 ] 1 [ A1 ] 2 [ A2 ] 12 [ A1 ] [ A2 ] Similar: In coordination chemistry In enzyme kinetics Metal Ion + Ligand 1 + Ligand 2 Enzyme + Substrate + Inhibitor Dose-response curve What is there that is not poison? All things are poison and nothing without poison Solely the dose determines that a thing is not a poison